The COVID-19 pandemic disrupted health care delivery in the US,
1 which may have contributed to sharp increases in drug overdose mortality.
2 Mitigation strategies, such as stay-at-home orders and social distancing, delayed nonessential and emergency care and limited in-person medical visits. For Kentucky and Ohio, restrictions limiting access to medical care were most stringent from mid-March through the end of April 2020.
3-5 These changes disproportionately affected individuals with opioid use disorder (OUD), who already faced significant barriers accessing care.
6